Apixaban IMpurity 5 (BMS-591329-01)

Request For Quotation
Apixaban IMpurity 5 (BMS-591329-01) Suppliers list
Company Name: Quality Control Solutions Ltd.  
Tel: 0755-66853366 13670046396
Email: orders@qcsrm.com
Company Name: Roark Standards  
Tel: 0755-83552066 15986688328
Email: service@roarkstandards.com
Company Name: Shenzhen SUNGENING Bio-Medical Co., Ltd.  
Tel: 0755-28967200 13631290199
Email: wxf@sungening.com
Company Name: Jida Pharmaceutical Chemicals (Shanghai) Co., Ltd.  
Tel: 021-56383663,17717680878
Email: jidapharm@126.com
Company Name: Shenzhen Botel Biotechnology Co. Ltd.  
Tel: 13316949107 13316968096
Email: 1979313431@qq.com
Apixaban IMpurity 5 (BMS-591329-01) Basic information
Product Name:Apixaban IMpurity 5 (BMS-591329-01)
Synonyms:Apixaban IMpurity 5 (BMS-591329-01);1H-?Pyrazolo[3,?4-?c]?pyridine-?3-?carboxylic acid, 4,?5,?6,?7-?tetrahydro-?1-?(2-?methoxyphenyl)?-?7-?oxo-?6-?[4-?(2-?oxo-?1-?piperidinyl)?phenyl]?-?, ethyl ester;Apixaban Impurity 117;Apixaban Chloro Impurity
CAS:1801881-20-8
MF:C27H28N4O5
MW:488.54
EINECS:
Product Categories:
Mol File:1801881-20-8.mol
Apixaban IMpurity 5 (BMS-591329-01) Structure
Apixaban IMpurity 5 (BMS-591329-01) Chemical Properties
Boiling point 758.7±60.0 °C(Predicted)
density 1.34±0.1 g/cm3(Predicted)
pka0.78±0.20(Predicted)
Safety Information
MSDS Information
Apixaban IMpurity 5 (BMS-591329-01) Usage And Synthesis
Apixaban IMpurity 5 (BMS-591329-01) Preparation Products And Raw materials
Tag:Apixaban IMpurity 5 (BMS-591329-01)(1801881-20-8) Related Product Information
ethyl 6-(4-(5-chloropentanaMido)phenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate 1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-[4-(5-methyl-2-oxo-1-piperidinyl)phenyl]-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxamide 1-(4-IODO-PHENYL)-PIPERIDIN-2-ONE Ethyl (2Z)-chloro[(4-methoxyphenyl)hydrazono]ethanoate 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one ethyl 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate 1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone 1-(4-(2-methyl-6-oxopiperidin-1-yl)phenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester 1-(4-Nitrophenyl)-2-piperidinone 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one ETHYL (2E)-CHLORO[(4-CHLOROPHENYL)HYDRAZONO]ACETATE 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one Apixaban Impurity 8 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid Apixaban Impurity 34 Butanoic acid, 2-[(4-hydroxyphenyl)hydrazono]-3-oxo-, ethyl ester